DOLCEPHARMA
ActiveSummary
DOLCEPHARMA has been active since 2004 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €197,065 and a net result of €17,393. Equity is growing by about 6.8% per year across the filed financial years. Its solvency ranks better than 71% of 9,643 sector peers (NACE 46, financial year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).
History
Acts, filings and financial milestones
Next filing, financial year 2026, expected by
2026
29-06
NBB filing
Annual accounts filed
financial year 2025 · abbreviated format
2025
26-06
NBB filing
Annual accounts filed
financial year 2024 · micro format
2024
09-08
NBB filing
Annual accounts filed
financial year 2023 · micro format · 9 days late
2023
31-12
Financial
Highest result from 2018 to 2025net €47,470 ▲28.5%
Net result €47,470, the highest in the series.
26-09
NBB filing
Annual accounts filed
financial year 2022 · micro format · 57 days late
2022
25-08
NBB filing
Annual accounts filed
financial year 2021 · abbreviated format · 25 days late
2021
31-12
Financial
Equity above €150,000equity €175,166 ▲23.8%
A profit in every financial year since 2018 builds equity to €175,166.
08-09
NBB filing
Annual accounts filed
financial year 2020 · abbreviated format · 39 days late
2020
29-06
NBB filing
Annual accounts filed
financial year 2019 · abbreviated format
2019
28-08
NBB filing
Annual accounts filed
financial year 2018 · abbreviated format · 28 days late
2018
31-08
NBB filing
Annual accounts filed
financial year 2017 · abbreviated format · 31 days late
2017
31-08
NBB filing
Annual accounts filed
financial year 2016 · abbreviated format · 31 days late
Financial milestoneNBB filingFinancial milestones sit on the financial year-end date, not the filing date.Of the 21 annual accounts filed, the latest 10 are here; all 21 are under Financials.
0 of 2 deeds read
About the unread acts
We know of 2 Belgian Official Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.